Cargando…

Topical and Intralesional Immunotherapy for Melanoma In Situ: A Review

SIMPLE SUMMARY: The incidence of melanoma in situ has increased faster than invasive melanoma over the last decades. Correctly managing these lesions is crucial. The gold standard of treatment for MIS, including lentigo maligna (LM), is complete surgical excision with clear margins (>0.5–1 cm). H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez-Fernández, Sandra, González-Sixto, Beatriz, Espasandín-Arias, Martina, Soto-García, Diego, Flórez, Ángeles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526313/ https://www.ncbi.nlm.nih.gov/pubmed/37760438 http://dx.doi.org/10.3390/cancers15184468

Ejemplares similares

Topical and Intralesional Immunotherapy for the Management of Skin Cancer in Special Locations: Lips and Eyelids
por: Buján Bonino, Cecilia, et al.
Publicado: (2023)

Insights into the Molecular Mechanisms Behind Intralesional Immunotherapies for Advanced Melanoma
por: Vidovic, Dejan, et al.
Publicado: (2020)

Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma
por: Ferrucci, Pier Francesco, et al.
Publicado: (2021)

Topical and intralesional therapies for in-transitmelanoma
por: Henderson, Michael A
Publicado: (2019)

Intralesional therapy for advanced melanoma: promise and limitation
por: Agarwala, Sanjiv S.
Publicado: (2015)

Treatment of melanoma in-transit metastases with combination intralesional interleukin-2, topical imiquimod, and tretinoin 0.1% cream
por: Leventhal, Jonathan S., et al.
Publicado: (2016)

The efficacy and safety of intralesional Candida vaccine versus topical diphencyproprobenone in immunotherapy of verruca vulgaris: A randomized comparative study
por: EL-Komy, Mohamed H. M., et al.
Publicado: (2022)

Current status of intralesional agents in treatment of malignant melanoma
por: Zawit, Misam, et al.
Publicado: (2021)

Intralesional and topical glucocorticoids for pretibial myxedema: A case report and review of literature
por: Zhang, Fan, et al.
Publicado: (2018)

Intralesional immunotherapy for difficult to treat warts with Mycobacterium w vaccine
por: Garg, Shilpa, et al.
Publicado: (2014)

Treatment of In-Transit Melanoma With Intralesional Bacillus Calmette-Guérin (BCG) and Topical Imiquimod 5% Cream: A Report of 3 Cases
por: Kibbi, Nour, et al.
Publicado: (2015)

Durability of Complete Response to Intralesional Interleukin-2 for In-Transit Melanoma
por: Khoury, Sami, et al.
Publicado: (2021)

The Anti-Psoriatic Efficacy and Safety Profile of Topical and Intralesional Methotrexate: A Literature Review
por: Chaiyabutr, Chayada, et al.
Publicado: (2022)

The management of vulvovaginal warts using intralesional Bacillus Calmette–Guérin immunotherapy
por: Gupta, Sunil Kumar
Publicado: (2020)

Predictors of the Therapeutic Response to Intralesional Bivalent HPV Vaccine in Wart Immunotherapy
por: Hammad, Noha M., et al.
Publicado: (2021)

Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma
por: Thompson, John F., et al.
Publicado: (2014)

Additive Intralesional Interleukin-2 Improves Progression-Free Survival in a Distinct Subgroup of Melanoma Patients with Prior Progression under Immunotherapy
por: Rafei-Shamsabadi, David, et al.
Publicado: (2022)

Immunotherapy with Intralesional Candida Albicans Antigen in Resistant or Recurrent Warts: A Study
por: Majid, Imran, et al.
Publicado: (2013)

Triple Intralesional Antigen Immunotherapy versus Monoantigen in the Treatment of Multiple Recalcitrant Warts
por: Nofal, Ahmad A., et al.
Publicado: (2022)

A Comparative Study of Intralesional Acyclovir vs Immunotherapy for Treatment of Viral Warts
por: Meghana Reddy, E., et al.
Publicado: (2023)

Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis
por: Nilforoushzadeh, Mohammad Ali, et al.
Publicado: (2007)

Unusual presentation of angiolymphoid hyperplasia with eosinophilia treated with intralesional and topic corticosteroid combination therapy
por: Granieri, Giammarco, et al.
Publicado: (2021)

Comparison of the Efficacy of Intralesional Tranexamic Acid Versus Topical 4% Hydroquinone in Treating Melasma
por: Mushtaq, Shigref, et al.
Publicado: (2022)

Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection
por: Glencer, Alexa C., et al.
Publicado: (2021)

Intralesional Rose Bengal in melanoma elicits tumor immunity via HMGB1
por: Liu, Hao, et al.
Publicado: (2015)

Advances in Intralesional Therapy for Locoregionally Advanced and Metastatic Melanoma: Five Years of Progress
por: DePalo, Danielle K., et al.
Publicado: (2023)

Familial Graham-Little-Picardi-Lassueur syndrome across 3 generations
por: Soto-García, Diego, et al.
Publicado: (2022)

Using topical imiquimod for the management of positive in situ margins after melanoma resection
por: Pandit, Amrita S, et al.
Publicado: (2015)

Topical Treatment of Melanoma In Situ, Lentigo Maligna, and Lentigo Maligna Melanoma with Imiquimod Cream: A Systematic Review of the Literature
por: Vaienti, Silvia, et al.
Publicado: (2023)

Ultrasound-assisted intralesional corticosteroid infiltrations for patients with hidradenitis suppurativa
por: Luis, Salvador-Rodriguez, et al.
Publicado: (2020)

Proliferative and necrotizing otitis externa in a kitten: successful treatment with intralesional and topical corticosteroid therapy
por: MOMOTA, Yutaka, et al.
Publicado: (2016)

Intralesional and topical interferon therapy following incomplete primary excision of ocular surface squamous neoplasia
por: Rishi, Pukhraj, et al.
Publicado: (2016)

Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases
por: Radny, P, et al.
Publicado: (2003)

Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
por: Pourmaleki, Maryam, et al.
Publicado: (2022)

Topical imiquimod and cryotherapy in combination with systemic immunotherapy in unresectable stage IIIC melanoma
por: Yeh, Jennifer E., et al.
Publicado: (2022)

Success of Intralesional Purified Protein Derivative Immunotherapy in the Treatment of Anogenital Warts: A Case Report
por: Achdiat, Pati Aji, et al.
Publicado: (2022)

Can We Justify Intralesional Immunotherapy with Measles-mumps-rubella Vaccine for Recalcitrant Facial Warts?
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2022)

Evaluation of the Efficacy of Intralesional Measles, Mumps, and Rubella Vaccine with Intralesional Vitamin D3 as Immunotherapies in the Treatment of Recalcitrant Cutaneous Warts in Adult- A Randomized Placebo-Controlled Study
por: Mohta, Alpana, et al.
Publicado: (2021)

Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis
por: Layegh, Pouran, et al.
Publicado: (2011)

Intralesional Candida albicans antigen versus intralesional zinc sulfate in treatment of cutaneous warts
por: Youssef, Eman M. Kamal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2uddiaqlhs3gr1ibqtd36ltsja